Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001735276-23-000018
Filing Date
2023-02-27
Accepted
2023-02-27 16:13:02
Documents
2
Period of Report
2023-02-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 6116
2 EDGAR SUPPORTING DOCUMENT pyott_20231206poa.txt EX-24 4105
  Complete submission text file 0001735276-23-000018.txt   11711
Mailing Address C/O ALLERGAN 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
PYOTT DAVID E I (Reporting) CIK: 0001051578 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36407 | Film No.: 23674963

Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations